| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |